AHA GUIDELINES Bundle (free trial)

Atrial Fibrillation 2023 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/387790

Contents of this Issue

Navigation

Page 115 of 131

116 Management 10.8. Adult Congenital Heart Disease (ACHD) COR LOE Recommendations 1 B-NR 1. In adults with ACHD and AF, it is recommended to evaluate for and treat precipitating factors and reversible causes of AF, recognizing that residual hemodynamic sequalae may contribute to the occurrence of the arrhythmia. 1 C-LD 2. In adults with AF and moderate or complex congenital heart disease, electrophysiological procedures should be performed by operators with expertise in ACHD procedures and in collaboration with an ACHD cardiologist, ideally in specialized centers, when available. 1 C-LD 3. In adults with congenital heart disease and symptomatic or hemodynamically significant paroxysmal or persistent AF, an initial strategy of rhythm control is recommended regardless of lesion severity as AF in this population is often poorly tolerated. 2a B-NR 4. In symptomatic patients with simple congenital heart disease with AAD-refractory AF, it is reasonable to choose ablation over long-term antiarrhythmic therapies. 2b C-LD 5. In ACHD patients with AF undergoing PVI, it may be reasonable to include an ablative strateg y in the right atrium directed at reentrant arrhythmia secondary to atriotomy scars and the CTI. 2b C-LD 6. In adults with AF and moderate or severe forms of congenital heart disease, particularly those with low-flow states such as Fontan circulation, blind-ending cardiac chambers, and cyanosis, it may be reasonable to treat with anticoagulation independent of conventional risk score to reduce risk of thromboembolic events. 10.7. HCM

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Atrial Fibrillation 2023 Update